Jacobson TA - Search Results

1

Provider recommendations for patient-reported muscle symptoms on statin therapy: Insights from the Understanding Statin Use in America and Gaps in Patient Education survey.

Jacobson TA, Khan A, Maki KC, Brinton EA, Cohen JD. Jacobson TA, et al. J Clin Lipidol. 2018 Jan-Feb;12(1):78-88. doi: 10.1016/j.jacl.2017.09.006. Epub 2017 Oct 12. J Clin Lipidol. 2018. PMID: 29239815 Free article.

2

Improving health outcomes without increasing costs: maximizing the full potential of lipid reduction therapy in the primary and secondary prevention of coronary heart disease.

Jacobson TA. Jacobson TA. Curr Opin Lipidol. 1997 Dec;8(6):369-74. doi: 10.1097/00041433-199712000-00008. Curr Opin Lipidol. 1997. PMID: 9412778 Review.

3

The safety of aggressive statin therapy: how much can low-density lipoprotein cholesterol be lowered?

Jacobson TA. Jacobson TA. Mayo Clin Proc. 2006 Sep;81(9):1225-31. doi: 10.4065/81.9.1225. Mayo Clin Proc. 2006. PMID: 16970219 Review.

4

The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.

Harper CR, Jacobson TA. Harper CR, et al. Among authors: jacobson ta. Curr Opin Lipidol. 2007 Aug;18(4):401-8. doi: 10.1097/MOL.0b013e32825a6773. Curr Opin Lipidol. 2007. PMID: 17620856 Review.

5

Myopathy with statin-fibrate combination therapy: clinical considerations.

Jacobson TA. Jacobson TA. Nat Rev Endocrinol. 2009 Sep;5(9):507-18. doi: 10.1038/nrendo.2009.151. Epub 2009 Jul 28. Nat Rev Endocrinol. 2009. PMID: 19636324 Review.

6

Evidence-based management of statin myopathy.

Harper CR, Jacobson TA. Harper CR, et al. Among authors: jacobson ta. Curr Atheroscler Rep. 2010 Sep;12(5):322-30. doi: 10.1007/s11883-010-0120-9. Curr Atheroscler Rep. 2010. PMID: 20628837 Review.

7

The importance of non-HDL cholesterol reporting in lipid management.

Blaha MJ, Blumenthal RS, Brinton EA, Jacobson TA; National Lipid Association Taskforce on Non-HDL Cholesterol. Blaha MJ, et al. Among authors: jacobson ta. J Clin Lipidol. 2008 Aug;2(4):267-73. doi: 10.1016/j.jacl.2008.06.013. Epub 2008 Jun 28. J Clin Lipidol. 2008. PMID: 21291742

8

Statin-induced myopathy: a review and update.

Abd TT, Jacobson TA. Abd TT, et al. Among authors: jacobson ta. Expert Opin Drug Saf. 2011 May;10(3):373-87. doi: 10.1517/14740338.2011.540568. Epub 2011 Feb 23. Expert Opin Drug Saf. 2011. PMID: 21342078 Review.

9

Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.

Davidson MH, Ballantyne CM, Jacobson TA, Bittner VA, Braun LT, Brown AS, Brown WV, Cromwell WC, Goldberg RB, McKenney JM, Remaley AT, Sniderman AD, Toth PP, Tsimikas S, Ziajka PE, Maki KC, Dicklin MR. Davidson MH, et al. Among authors: jacobson ta. J Clin Lipidol. 2011 Sep-Oct;5(5):338-67. doi: 10.1016/j.jacl.2011.07.005. J Clin Lipidol. 2011. PMID: 21981835

10

Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review.

Jacobson TA, Glickstein SB, Rowe JD, Soni PN. Jacobson TA, et al. J Clin Lipidol. 2012 Jan-Feb;6(1):5-18. doi: 10.1016/j.jacl.2011.10.018. Epub 2011 Nov 3. J Clin Lipidol. 2012. PMID: 22264569 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters